MedPath

Constrained Balloon Combined With Drug-coated Balloon Angioplasty for Femoropopliteal Lesion

Recruiting
Conditions
Peripheral Arterial Disease
Interventions
Device: Chocolate balloon
Registration Number
NCT05894460
Lead Sponsor
Xuanwu Hospital, Beijing
Brief Summary

This study will assess the safety and efficacy of Chocolate balloons as a combination with drug-coated balloons in the treatment of popliteal artery lesions in lower limb atherosclerotic occlusive disease and will compare them with conventional balloons.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
254
Inclusion Criteria
  • Rutherford classification of 2-6 in patients with femoropopliteal atherosclerotic occlusive disease;
  • primary cases with no previous surgical treatment of the target lesion;
  • presence of at least one vessel with patency in the distal outflow tract;
  • survival >1 year.
Exclusion Criteria
  • planned stenting;
  • presence of flow-limiting dissection prior to application of Chocolate balloon and conventional balloon dilation of the target lesion;
  • combination of severe organ dysfunction of the heart, lungs and brain that cannot tolerate the procedure;
  • allergy to contrast agents, anaesthetic drugs, anticoagulants and anti-platelet drugs;
  • ineffective recanalization attempts;
  • lesions within or adjacent to the aneurysm, or the presence of a popliteal aneurysm.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Chocolate balloonChocolate balloon-
Conventional ballonChocolate balloon-
Primary Outcome Measures
NameTimeMethod
Primary patency12 months

No occlusion or restenosis (\>50%) of the target vessel in the treated segment during follow-up and no further intervention is required.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Xuanwu Hospital

🇨🇳

Beijing, None Selected, China

© Copyright 2025. All Rights Reserved by MedPath